Leronlimab (PRO 140) in vitro activity against 4-class drug resistant HIV-1 from heavily treatment experienced subjects
Academic Article
Publication Date:
2022
Short description:
Leronlimab (PRO 140) in vitro activity against 4-class drug resistant HIV-1 from heavily treatment experienced subjects / Rusconi, S., Saladini, F., Bellocchi, M.C., Galli, L., Gagliardini, R., Gazzola, L., Francisci, D., Vichi, F., Foca, E., Zazzi, M., Santoro, M.M., Gabrieli, A., Castagna, A.. - In: PHARMACOLOGICAL RESEARCH. - ISSN 1043-6618. - 176:(2022), p. 106064. [10.1016/j.phrs.2022.106064]
Iris type:
1.1 Articolo in rivista
Keywords:
Drug resistance; Genotype; Human immunodeficiency virus type 1; Leronlimab; Maraviroc; Phenotype
List of contributors:
Rusconi, S.; Saladini, F.; Bellocchi, M. C.; Galli, L.; Gagliardini, R.; Gazzola, L.; Francisci, D.; Vichi, F.; Foca, E.; Zazzi, M.; Santoro, M. M.; Gabrieli, A.; Castagna, A.
Published in: